Sensei Biotherapeutics Employees

As of December 31, 2024, Sensei Biotherapeutics had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 13 or -46.43% compared to the previous year.

Employees

Change (1Y)

-13

Growth (1Y)

-46.43%

Revenue / Employee

n/a

Profits / Employee

-$1,609,200

Market Cap

36.61M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	15	-13	-46.43%
Dec 31, 2023	28	0	-
Dec 31, 2022	28	-28	-50.00%
Dec 31, 2021	56	24	75.00%
Dec 31, 2020	32	-	-

Related Stocks

Company Name	Employees
Xilio Therapeutics	64
Atara Biotherapeutics	38
Jasper Therapeutics	27
Lisata Therapeutics	26
Actinium Pharmaceuticals	25
PDS Biotechnology	24
Veru Inc.	20
CervoMed	15

Employee Rankings

SNSE News

12 days ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
19 days ago - Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire
2 months ago - Egle Therapeutics Appoints John Celebi as Chief Executive Officer - GlobeNewsWire
4 months ago - Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
4 months ago - Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value - GlobeNewsWire
5 months ago - Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025 - GlobeNewsWire
5 months ago - Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 - GlobeNewsWire
6 months ago - Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire

More News